A TCP model for external beam treatment of intermediate-risk prostate cancer.
AffiliationSchool of Physics, National University of Ireland Galway, Connacht, Ireland. Walshsharp@gmail.com
MetadataShow full item record
CitationA TCP model for external beam treatment of intermediate-risk prostate cancer. 2013, 40 (3):031709 Med Phys
AbstractBiological models offer the ability to predict clinical outcomes. The authors describe a model to predict the clinical response of intermediate-risk prostate cancer to external beam radiotherapy for a variety of fractionation regimes.
- A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy.
- Authors: Walsh S, Roelofs E, Kuess P, Lambin P, Jones B, Georg D, Verhaegen F
- Issue date: 2016 Feb
- Hypofractionation: what does it mean for prostate cancer treatment?
- Authors: Liao Y, Joiner M, Huang Y, Burmeister J
- Issue date: 2010 Jan 1
- Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose.
- Authors: Wang JZ, Li XA
- Issue date: 2003 Jan
- Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
- Authors: D'Souza WD, Thames HD, Kuban DA
- Issue date: 2004 Apr 1
- Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
- Authors: Luxton G, Hancock SL, Boyer AL
- Issue date: 2004 May 1